NASDAQ: ARGX
Argenx Se Stock

$603.40-2.47 (-0.41%)
Updated Dec 12, 2024
ARGX Price
$603.40
Fair Value Price
N/A
Market Cap
$36.08B
52 Week Low
$327.73
52 Week High
$630.00
P/E
-158.62x
P/B
7.79x
P/S
661.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$39.02M
Earnings
-$219.73M
Gross Margin
-376.5%
Operating Margin
-646.91%
Profit Margin
-569.3%
Debt to Equity
0.13
Operating Cash Flow
-$304M
Beta
0.75
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ARGX Overview

"a"r"g"e"n"x" "S"E"," "a" "b"i"o"t"e"c"h"n"o"l"o"g"y" "c"o"m"p"a"n"y"," "f"o"c"u"s"e"s" "o"n" "d"e"v"e"l"o"p"i"n"g" "v"a"r"i"o"u"s" "t"h"e"r"a"p"i"e"s" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "a"u"t"o"i"m"m"u"n"e" "d"i"s"e"a"s"e"s" "i"n" "t"h"e" "U"n"i"t"e"d" "S"t"a"t"e"s"," "t"h"e" "N"e"t"h"e"r"l"a"n"d"s"," "B"e"l"g"i"u"m"," "J"a"p"a"n"," "S"w"i"t"z"e"r"l"a"n"d"," "G"e"r"m"a"n"y" "a"n"d" "F"r"a"n"c"e"." "I"t"s" "l"e"a"d" "p"r"o"d"u"c"t" "c"a"n"d"i"d"a"t"e" "i"s" "e"f"g"a"r"t"i"g"i"m"o"d" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "p"a"t"i"e"n"t"s" "w"i"t"h" "m"y"a"s"t"h"e"n"i"a" "g"r"a"v"i"s"," "i"m"m"u"n"e" "t"h"r"o"m"b"o"c"y"t"o"p"e"n"i"a"," "p"e"m"p"h"i"g"u"s" "v"u"l"g"a"r"i"s"," "a"n"d" "c"h"r"o"n"i"c" "i"n"f"l"a"m"m"a"t"o"r"y" "d"e"m"y"e"l"i"n"a"t"i"n"g" "p"o"l"y"n"e"u"r"o"p"a"t"h"y" "i"n" "P"h"a"s"e" "I"I"I" "c"l"i"n"i"c"a"l" "t"r"i"a"l"s";" "b"u"l"l"o"u"s" "p"e"m"p"h"i"g"o"i"d" "a"n"d" "i"d"i"o"p"a"t"h"i"c" "i"n"f"l"a"m"m"a"t"o"r"y" "m"y"o"p"a"t"h"y" "i"n" "P"h"a"s"e" "I"I"/"I"I"I" "c"l"i"n"i"c"a"l" "t"r"i"a"l"s";" "a"n"d" "E"N"H"A"N"Z"E" "S"C" "i"n" "P"r"e"-"c"l"i"n"i"c"a"l" "s"t"u"d"y"." "T"h"e" "c"o"m"p"a"n"y" "i"s" "a"l"s"o" "d"e"v"e"l"o"p"i"n"g" "i"m"m"u"n"o"l"o"g"y" "i"n"n"o"v"a"t"i"o"n" "p"r"o"g"r"a"m"s"," "i"n"c"l"u"d"i"n"g" "c"u"s"a"t"u"z"u"m"a"b" "f"o"r" "h"e"m"a"t"o"l"o"g"i"c"a"l" "c"a"n"c"e"r"," "a"s" "w"e"l"l" "a"s" "h"i"g"h" "r"i"s"k" "M"D"S";" "A"R"G"X"-"1"1"9"," "a"n" "a"n"t"i"b"o"d"y" "t"h"a"t" "t"a"r"g"e"t"s" "m"u"s"c"l"e"-"s"p"e"c"i"f"i"c" "t"y"r"o"s"i"n"e" "k"i"n"a"s"e" "s"t"a"g"e";" "A"R"G"X"-"1"1"7" "f"o"r" "s"e"v"e"r"e" "a"u"t"o"i"m"m"u"n"e" "i"n"d"i"c"a"t"i"o"n"s";" "A"R"G"X"-"1"1"8" "f"o"r" "a"i"r"w"a"y" "i"n"f"l"a"m"m"a"t"i"o"n";" "a"n"d" "A"R"G"X"-"1"2"0" "t"o" "t"r"e"a"t" "a"u"t"o"i"m"m"u"n"e" "d"i"s"e"a"s"e"s"." "I"n" "a"d"d"i"t"i"o"n"," "i"t"s" "p"a"r"t"n"e"r"e"d" "p"r"o"d"u"c"t" "c"a"n"d"i"d"a"t"e"s" "i"n"c"l"u"d"e" "A"R"G"X"-"1"1"5" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "c"a"n"c"e"r";" "A"R"G"X"-"1"1"2" "t"o" "t"r"e"a"t" "i"n"t"e"r"l"e"u"k"i"n"-"2"2" "r"e"c"e"p"t"o"r";" "a"n"d" "A"R"G"X"-"1"1"4"," "a"n" "a"n"t"i"b"o"d"y" "d"i"r"e"c"t"e"d" "a"g"a"i"n"s"t" "t"h"e" "M"E"T" "r"e"c"e"p"t"o"r"." "T"h"e" "c"o"m"p"a"n"y" "h"a"s" "s"t"r"a"t"e"g"i"c" "p"a"r"t"n"e"r"s"h"i"p" "w"i"t"h" "A"b"b"V"i"e" "S"."À"."R"."L"."," "Z"a"i" "L"a"b" "L"i"m"i"t"e"d"," "a"n"d" "L"E"O" "P"h"a"r"m"a" "A"/"S";" "a"n"d" "c"o"l"l"a"b"o"r"a"t"i"o"n" "a"n"d" "l"i"c"e"n"s"e" "a"g"r"e"e"m"e"n"t" "w"i"t"h" "G"e"n"o"r" "B"i"o"p"h"a"r"m"a" "C"o"." "L"t"d"," "U"n"i"v"e"r"s"i"t"é" "C"a"t"h"o"l"i"q"u"e" "d"e" "L"o"u"v"a"i"n"," "S"o"p"a"r"t"e"c" "S"."A"."," "N"Y"U" "L"a"n"g"o"n"e" "H"e"a"l"t"h"," "L"e"i"d"e"n" "U"n"i"v"e"r"s"i"t"y" "M"e"d"i"c"a"l" "C"e"n"t"e"r"," "A"g"o"m"A"b" "T"h"e"r"a"p"e"u"t"i"c"s" "N"V"," "B"r"o"t"e"i"o" "P"h"a"r"m"a" "B"."V"."," "U"n"i"v"e"r"s"i"t"y" "o"f" "T"e"x"a"s"," "B"i"o"W"a"," "I"n"c"."," "C"i"l"a"g" "G"m"b"H" "I"n"t"e"r"n"a"t"i"o"n"a"l"," "S"t"a"t"e"n" "B"i"o"t"e"c"h"n"o"l"o"g"y" "B"."V"."," "a"n"d" "S"h"i"r"e" "I"n"t"e"r"n"a"t"i"o"n"a"l" "G"m"b"H"." "a"r"g"e"n"x" "S"E" "w"a"s" "i"n"c"o"r"p"o"r"a"t"e"d" "i"n" "2"0"0"8" "a"n"d" "i"s" "b"a"s"e"d" "i"n" "B"r"e"d"a"," "t"h"e" "N"e"t"h"e"r"l"a"n"d"s"."

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ARGX's potential to beat the market

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
ARGX
Ranked
Unranked of 551

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$19.01A
$6.38A
$18.67A
View Top Biotech Stocks

Be the first to know about important ARGX news, forecast changes, insider trades & much more!

ARGX News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ARGX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ARGX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ARGX is poor value based on its book value relative to its share price (7.79x), compared to the US Biotechnology industry average (5.46x)
P/B vs Industry Valuation
ARGX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ARGX due diligence checks available for Premium users.

Valuation

ARGX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-158.62x
Industry
-102.22x
Market
29.87x

ARGX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
7.79x
Industry
5.46x
ARGX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ARGX's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ARGX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ARGX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.2B
Liabilities
$574.5M
Debt to equity
0.13
ARGX's short-term assets ($4.63B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ARGX's short-term assets ($4.63B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ARGX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ARGX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
ARGX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ARGX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ARGX$36.08B-0.41%-158.62x7.79x
ALNYC$31.63B-3.50%-93.97x977.74x
BNTX$28.93B+1.13%-57.86x1.41x
BGNE$19.24B-2.23%-281.67x5.60x
MRNAC$16.48B-0.09%-7.37x1.38x

Argenx Se Stock FAQ

What is Argenx Se's quote symbol?

(NASDAQ: ARGX) Argenx Se trades on the NASDAQ under the ticker symbol ARGX. Argenx Se stock quotes can also be displayed as NASDAQ: ARGX.

If you're new to stock investing, here's how to buy Argenx Se stock.

What is the 52 week high and low for Argenx Se (NASDAQ: ARGX)?

(NASDAQ: ARGX) Argenx Se's 52-week high was $630.00, and its 52-week low was $327.73. It is currently -4.22% from its 52-week high and 84.12% from its 52-week low.

How much is Argenx Se stock worth today?

(NASDAQ: ARGX) Argenx Se currently has 59,796,273 outstanding shares. With Argenx Se stock trading at $603.40 per share, the total value of Argenx Se stock (market capitalization) is $36.08B.

Argenx Se stock was originally listed at a price of $23.00 in May 18, 2017. If you had invested in Argenx Se stock at $23.00, your return over the last 7 years would have been 2,523.48%, for an annualized return of 59.48% (not including any dividends or dividend reinvestments).

How much is Argenx Se's stock price per share?

(NASDAQ: ARGX) Argenx Se stock price per share is $603.40 today (as of Dec 12, 2024).

What is Argenx Se's Market Cap?

(NASDAQ: ARGX) Argenx Se's market cap is $36.08B, as of Dec 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Argenx Se's market cap is calculated by multiplying ARGX's current stock price of $603.40 by ARGX's total outstanding shares of 59,796,273.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.